European Union

EPO Patent Application: Human Antibody Against Coronavirus Mutant Strain

The European Patent Office has published patent application EP2026029035A1 concerning a human antibody against a coronavirus mutant strain. The publication date is March 18, 2026, and the application includes various International Patent Classification codes related to antibodies and their therapeutic uses.

EPO Patent Publication: Polymer, Crosslinked Body, Medical Composition

The European Patent Office (EPO) has published a patent application (EP2026028918A1) related to polymers, crosslinked bodies, and medical compositions. The publication date is March 18, 2026, and it includes various IPC classifications related to medical materials and polymers.

EPO Patent Application: Plant Autophagy Regulation for Protein Accumulation

The European Patent Office has published patent application EP2026030502A1 concerning the regulation of plant autophagy to enhance recombinant protein accumulation. The application details methods and compositions for improving protein production in plants, with a publication date of March 18, 2026.

EPO Patent Publication: Gene Insertion and Expression Methods

The European Patent Office has published a patent application (EP2026030518A1) detailing methods for improved gene insertion and expression in cell lines. The publication date is March 18, 2026, and it covers various IPC classifications related to genetic engineering and cell culture.

EPO Patent Application: Double-Stranded RNA for RSV-B

The European Patent Office has published a new patent application, EP2026028971A1, concerning novel double-stranded RNA based on the RSV-B RNA sequence and its therapeutic uses. The publication date is March 18, 2026, and the inventors have not yet been designated.

EPO Patent Publication: Vaccine Antigens and Use Thereof

The European Patent Office (EPO) has published patent application EP2026030201A2 concerning vaccine antigens and their use. The publication date is March 18, 2026. The inventors have not yet filed their designation.

EPO Patent Publication: Urea or Carbamate Lipid Nanoparticles

The European Patent Office (EPO) has published a patent application (EP2026029046A1) concerning urea or carbamate lipids with cyclic groups in the side chain, and related lipid nanoparticles and pharmaceutical compositions. The publication date is March 18, 2026.

EPO Patent Publication: Compositions for Treating Cancers

The European Patent Office has published patent application EP2026030629A1 concerning compositions and methods for treating cancers. The publication date is March 18, 2026, and it includes various International Patent Classification codes related to pharmaceutical compositions and medical treatments.

EPO Patent Publication: Intestinal Organoid and Method for Producing Same

The European Patent Office (EPO) has published patent application EP2026029043A1 concerning an intestinal organoid and a method for its production. The publication date is March 18, 2026. The inventors have not yet been designated.

EPO Patent Publication: Engineered Producer Cell

The European Patent Office (EPO) has published a patent application (EP2026030520A1) related to engineered producer cells and methods for their production and use. The publication date is March 18, 2026, and it covers multiple designated states within the European Union.